These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20684432)

  • 1. [When creams turn into a burden].
    Failla V; Wauters O; Raty L; Caucanas M; Richert B; Dezfoulian B; Nikkels AF
    Rev Med Liege; 2010; 65(5-6):423-5. PubMed ID: 20684432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-adherence and measures to improve adherence in the topical treatment of psoriasis.
    Zschocke I; Mrowietz U; Karakasili E; Reich K
    J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():4-9. PubMed ID: 24684738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment adherence: a hurdle for real-life effectiveness in psoriasis?
    Reich K; Daudén E
    J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():1-3. PubMed ID: 24684737
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical treatment of psoriasis.
    Laws PM; Young HS
    Expert Opin Pharmacother; 2010 Aug; 11(12):1999-2009. PubMed ID: 20569091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence and patient satisfaction with topical treatment in psoriasis, and the use, and organoleptic properties of such treatments: a Delphi study with an expert panel and members of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology.
    Puig L; Carrascosa JM; Belinchón I; Fernández-Redondo V; Carretero G; Ruiz-Carrascosa JC; Careaga JM; de la Cueva P; Gárate MT; Ribera M; ;
    Actas Dermosifiliogr; 2013; 104(6):488-96. PubMed ID: 23395400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease burden and treatment adherence in psoriasis patients.
    Feldman SR
    Cutis; 2013 Nov; 92(5):258-63. PubMed ID: 24343214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis: improving adherence to topical therapy.
    Feldman SR; Horn EJ; Balkrishnan R; Basra MK; Finlay AY; McCoy D; Menter A; van de Kerkhof PC;
    J Am Acad Dermatol; 2008 Dec; 59(6):1009-16. PubMed ID: 18835062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' educational needs about topical treatments for psoriasis.
    Martin SL; McGoey ST; Bebo BF; Feldman SR
    J Am Acad Dermatol; 2013 Jun; 68(6):e163-8. PubMed ID: 22682885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adherence of local (and general) treatments in psoriasis].
    Cribier B
    Ann Dermatol Venereol; 2012 Jan; 139 Suppl 1():S13-7. PubMed ID: 22305281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expert recommendations: the use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis.
    Daudén E; Bewley A; Lambert J; Girolomoni G; Cambazard F; Reich K
    J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():22-32. PubMed ID: 24684740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current effective topical therapies in the management of psoriasis.
    Kurian A; Barankin B
    Skin Therapy Lett; 2011 Jan; 16(1):4-7. PubMed ID: 21293834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In touch with psoriasis: topical treatments and current guidelines.
    Murphy G; Reich K
    J Eur Acad Dermatol Venereol; 2011 Jun; 25 Suppl 4():3-8. PubMed ID: 21507077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study.
    Thaçi D; Ortonne JP; Chimenti S; Ghislain PD; Arenberger P; Kragballe K; Saurat JH; Khemis A; Sprøgel P; Esslinger HU; Unnebrink K; Kupper H
    Br J Dermatol; 2010 Aug; 163(2):402-11. PubMed ID: 20377585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Topical treatment adherence for psoriasis].
    Halioua B
    Rev Prat; 2012 Feb; 62(2):156-9. PubMed ID: 22408849
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of treatment modalities for psoriasis.
    Tristani-Firouzi P; Krueger GG
    Cutis; 1998 Feb; 61(2 Suppl):11-21. PubMed ID: 9787987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical management of psoriasis - corticosteroids and sparing corticosteroid therapy.
    Gorgievska Sukarovska B; Lipozencić J
    Acta Dermatovenerol Croat; 2006; 14(3):188-96. PubMed ID: 17010269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practicability of combined treatment with calcipotriol/betamethasone gel (Daivobet® Gel) and improvement of quality of life in patients with psoriasis.
    Sticherling M; Eicke C; Anger T
    J Dtsch Dermatol Ges; 2013 May; 11(5):420-7. PubMed ID: 23437972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Coral reef' psoriasis: a marker of resistance to topical treatment.
    Feldman SR; Brown KL; Heald P
    J Dermatolog Treat; 2008; 19(5):257-8. PubMed ID: 18608734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of safety and compliance in determining effectiveness of topical therapy for psoriasis.
    Stein Gold L; Corvari L
    Cutis; 2007 Jan; 79(1 Suppl 2):32-8. PubMed ID: 17367043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guidelines for high-quality use of biologic therapies in adults with plaque psoriasis].
    Marques Pinto G; Filipe P
    Acta Med Port; 2012; 25(2):125-41. PubMed ID: 22985925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.